C29H28F3NO11
Neat
623.53
+5°C
Room Temperature
26388-52-3; Trifluoroacetyldaunomycin; N-(Trifluoroacetyl)daunomycin; RefChem:191586; N-(Trifluoroacetyl)daunorubicin; N-[(2S, 3S, 4S, 6R)-6-[[(1S, 3S)-3-acetyl-3, 5, 12-trihydroxy-10-methoxy-6, 11-dioxo-2, 4-dihydro-1H-tetracen-1-yl]oxy]-3-hydroxy-2-methyloxan-4-yl]-2, 2, 2-trifluoroacetamide; N-(Trifluoroacetyl)daunomycin; (8S, 10S)-8-Acetyl-7, 8, 9, 10-tetrahydro-6, 8, 11-trihydroxy-1-methoxy-10-[[2, 3, 6-trideoxy-3-[(2, 2, 2-trifluoroacetyl)amino]-a-L-lyxo-hexopyranosyl]oxy]-5, 12-naphthacenedione;; N-trifluoroacetyldaunorubicin; CHEMBL383543; Idarubicin HCL Intermediates 1; DTXSID50949278; 3-Acetyl-3, 5, 12-trihydroxy-10-methoxy-6, 11-dioxo-1, 2, 3, 4, 6, 11-hexahydrotetracen-1-yl 2, 3, 6-trideoxy-3-[(2, 2, 2-trifluoro-1-hydroxyethylidene)amino]hexopyranoside; 5, 12-Naphthacenedione, 8-acetyl-7, 8, 9, 10-tetrahydro-6, 8, 11-trihydroxy-1-methoxy-10-((2, 3, 6-trideoxy-3-((trifluoroacetyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)- and (8S-cis)-
N-[(2S, 3S, 4S, 6R)-6-[[(1S, 3S)-3-acetyl-3, 5, 12-trihydroxy-10-methoxy-6, 11-dioxo-2, 4-dihydro-1H-tetracen-1-yl]oxy]-3-hydroxy-2-methyloxan-4-yl]-2, 2 and 2-trifluoroacetamide
InChI=1S/C29H28F3NO11/c1-10-22(35)14(33-27(40)29(30,31)32)7-17(43-10)44-16-9-28(41,11(2)34)8-13-19(16)26(39)21-20(24(13)37)23(36)12-5-4-6-15(42-3)18(12)25(21)38/h4-6,10,14,16-17,22,35,37,39,41H,7-9H2,1-3H3,(H,33,40)/t10-,14-,16-,17-,22+,28-/m0/s1